文献速递颈动脉与弓上血管

非动脉粥样硬化性颈动脉疾病的颈动脉支架术结果

Outcomes of carotid artery stenting for nonatherosclerotic disease.
PubMed 文献 · J Vasc Surg · 2025-06-08

TCAR与更低的MACE(1.2% vs 7%;P=.004)和卒中/死亡(1.2% vs 6.4%;P=.007)相关,多因素分析中TCAR独立关联更低的MACE(OR 0.09;95%CI 0.01-0.74;P=.025)和卒中/死亡(OR 0.11;95%CI 0.01-0.95;P=.045)风险。

要点

  • TCAR组MACE 1.2% vs tfCAS组7%(P=.004),卒中/死亡1.2% vs 6.4%(P=.007)。
  • 多因素分析TCAR独立关联更低MACE(OR 0.09;95%CI 0.01-0.74)和卒中/死亡(OR 0.11;95%CI 0.01-0.95)。
  • TCAR透视时间5分钟 vs tfCAS 18.25分钟,造影剂30 mL vs 95 mL(均P<.001)。

核心结论

  • 在非动脉粥样硬化性颈动脉疾病治疗中,TCAR与优于tfCAS的围术期结局相关,提示TCAR可能是该患者群体更安全有效的治疗选择。

主要发现

  • TCAR组年龄64±14岁 vs tfCAS组56±16岁(P<.001),高血压74% vs 60.4%(P=.001),冠心病34.1% vs 22.2%(P=.002)。
  • 病因分布:夹层TCAR 77.5% vs tfCAS 77.9%,肌纤维发育不良TCAR 14.5% vs tfCAS 10.5%,创伤TCAR 8.1% vs tfCAS 11.5%。
  • TCAR组透视时间5分钟 vs tfCAS组18.25分钟(P<.001),造影剂用量30 mL vs 95 mL(P<.001),手术时间75.5分钟 vs 69分钟(P=.055)。
  • TCAR组MACE 1.2% vs tfCAS组7%(P=.004),卒中/死亡1.2% vs 6.4%(P=.007);按症状状态分层后TCAR组MACE和卒中/死亡仍较低。
  • 多因素分析:TCAR独立关联更低MACE(OR 0.09;95%CI 0.01-0.74;P=.025)和卒中/死亡(OR 0.11;95%CI 0.01-0.95;P=.045)。

临床怎么用

  • 对于非动脉粥样硬化性颈动脉疾病患者,TCAR与更低的围术期MACE和卒中/死亡风险相关,且透视时间和造影剂用量更少。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aims to evaluate and compare the outcomes of transcarotid artery revascularization (TCAR) and transfemoral carotid artery stenting (tfCAS) in patients with nonatherosclerotic carotid diseases, including dissection, trauma, and fibromuscular dysplasia. METHODS: Patients who underwent TCAR and tfCAS for nonatherosclerotic carotid diseases between 2016 and 2024 were identified in the Vascular Quality Initiative (VQI) database. Patients were classified into TCAR or tfCAS based on the procedure performed. Baseline characteristics, demographics, and operative details were collected. Primary outcomes included stroke, death, and major adverse cardiovascular events (MACE), which was defined as the composite of stroke, myocardial infarction, and death. Secondary outcomes included perioperative complications. Descriptive statistics, univariable comparisons, and multivariable logistic regression analyses were performed to evaluate the association between procedure type and outcomes. A two-tailed P value of <.05 was considered statistically significant. RESULTS: Six hundred seventy six patients were identified (tfCAS, n = 503; TCAR, n = 173). TCAR patients were older (64 ± 14 years vs 56 ± 16 years; P < .001), and had higher rates of hypertension (74% vs 60.4%; P = .001) and coronary artery disease (34.1% vs 22.2%; P = .002). Dissection was the most common etiology (TCAR, 77.5%; tfCAS, 77.9%), followed by fibromuscular dysplasia (TCAR, 14.5%; tfCAS, 10.5%) then trauma (TCAR, 8.1%; tfCAS, 11.5%). Intraoperatively, TCAR patients had shorter fluoroscopy times (5 minutes vs 18.25 minutes; P < .001) and required less radiocontrast (30 mL vs 95 mL; P < .001), but had slightly longer procedure times (75.5 minutes vs 69 minutes; P = .055). When analyzed by procedure type, TCAR was associated with significantly lower rates of MACE (1.2% vs 7%; P = .004) and stroke/death (1.2% vs 6.4%; P = .007) compared with tfCAS. Furthermore, when stratified by symptomatic status, TCAR consistently had lower rates of MACE and stroke/death. On multivariate analysis, TCAR was independently associated with a significantly lower risk of MACE (odds ratio, 0.09; 95% confidence interval, 0.01-0.74; P = .025) and stroke/death (odds ratio, 0.11; 95% confidence interval, 0.01-0.95; P = .045). CONCLUSIONS: TCAR was associated with superior perioperative outcomes compared with tfCAS in the treatment of nonatherosclerotic carotid diseases. These findings highlight TCAR's potential to be a safer and more effective treatment option for this challenging patient population.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Halabi M, Chamseddine H, Shepard A, et al. Outcomes of carotid artery stenting for nonatherosclerotic disease. J Vasc Surg. 2025. PMID: 40483606. doi:10.1016/j.jvs.2025.04.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。